Founded in 2021, Algorithmic Biologics operates in Health Tech industry. Originally focused on enhancing DNA synthesis and sequencing processes, the company has evolved to incorporate machine learning...
Funding stage:
Seed
Last funding:
02/02/2024
Total funding:
$2.49 Mn+
Revenue:
Investors
Employee count:
18
Last 90d
18
Last 90d
Web traffic:
897
897
Last 30d
Last 30d
Glassdoor Rating:
Algorithmic Biologics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders6
Latest Filing Date22 Nov 2023- Funding Events9
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Algorithmic Biologics
As of 23 November 2023, Algorithmic Biologics's equity is held by 5 shareholders, with the top three being Manoj Gopalkrishnan, Axilor Technology Fund I, and Bharat Innovation Fund.
Manoj Gopalkrishnan holds the largest stake in Algorithmic Biologics at 45.9% as of 23 November 2023.
As of 23 November 2023, founders collectively hold 45.9% equity in Algorithmic Biologics.
As of 23 November 2023, investors collectively hold 43.5% equity in Algorithmic Biologics.
Algorithmic Biologics's ESOP pool stands at 10.6% of total equity as of 23 November 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links